Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-08-27

Clinical Trial Update: Varenicline for the Treatment of Cannabis and Tobacco Use Disorders in Veterans [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating varenicline for tobacco use disorder and cannabis use disorder in veterans has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Tobacco Use Disorder, Cannabis Use Disorder | Phase 2 | Status: WITHDRAWN